Barbara Schraml
@barbaraschraml.bsky.social
Immunologist, with a passion for dendritic cells, neonatal immunity and immune development.
@schraml-lab.de
@schraml-lab.de
Check out our work: 👇https://www.pnas.org/doi/10.1073/pnas.2417308122
RORγt-expressing DCs can activate naive T cells and have pro-inflammatory features in autoimmune inflammation. But these cells can also induce T cell tolerance highlighting their therapeutic potential in autoimmunity and cancer.
RORγt-expressing DCs can activate naive T cells and have pro-inflammatory features in autoimmune inflammation. But these cells can also induce T cell tolerance highlighting their therapeutic potential in autoimmunity and cancer.
March 12, 2025 at 10:10 AM
Check out our work: 👇https://www.pnas.org/doi/10.1073/pnas.2417308122
RORγt-expressing DCs can activate naive T cells and have pro-inflammatory features in autoimmune inflammation. But these cells can also induce T cell tolerance highlighting their therapeutic potential in autoimmunity and cancer.
RORγt-expressing DCs can activate naive T cells and have pro-inflammatory features in autoimmune inflammation. But these cells can also induce T cell tolerance highlighting their therapeutic potential in autoimmunity and cancer.
Thank you Katha. Truly a lot of work. Grateful for your support.
March 10, 2025 at 9:39 PM
Thank you Katha. Truly a lot of work. Grateful for your support.